World Rheumatoid Arthritis Day on February 2, 2025, is a powerful reminder of the importance of understanding rheumatoid ...

February 2 is observed as Rheumatoid Arthritis Awareness Day to raise awareness about the condition, its causes, symptoms, treatment options, and more ...

February 2, 2025, marks Rheumatoid Arthritis Awareness Day—a day dedicated to shedding light on a debilitating disease that affects millions worldwide. While scientific literature extensively covers ...

Medically reviewed by Stella Bard, MD Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common types of ...

Current research has not found an association between rheumatoid arthritis and appendicitis, but some studies found a link between other autoimmune diseases and appendicitis.

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

Rheumatoid Arthritis Awareness Day 2025 falls on February 2 to raise awareness around the chronic autoimmune disease.

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of rheumatoid arthritis, a chronic autoimmune disease that affects about 1.5 million ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.